Results 111 to 120 of about 1,697,865 (308)

PUBLIC GOODS, CORRUPTION AND GROWTH??? [PDF]

open access: yes
In this paper, we analyse implications of corruption on growth. We extend existing growth models by incorporating ubiquitous corruption as a by-product of the public sector. Corruption affects both taxation and public good provision, and therefore causes
Ratbek Dzhumashev
core  

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch   +13 more
wiley   +1 more source

Subscription equilibria with public production: Existence and regularity [PDF]

open access: yes
We revisit the analysis of subscription equilibria in a full fledged general equilibrium model with public goods. We study the case of a nonprofit, or public, firm that produces the public good using private goods as inputs, which are to be financed by ...
Villanacci, Antonio, Zenginobuz, Unal
core   +1 more source

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

open access: yesMolecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric   +10 more
wiley   +1 more source

Good publication practice [PDF]

open access: yesActa Obstetricia et Gynecologica Scandinavica, 1994
openaire   +2 more sources

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Public goods

open access: yes, 2019
Supplying public goods generates costs and benefits that can be allocated among individuals in different ways. Yet leading theories of justice within liberalism fail to offer concrete guidance on how these allocations should be assessed. This chapter critically examines a number of principles of distributive justice that might be used for this purpose.
Miller, D, Taylor, I
openaire   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner   +14 more
wiley   +1 more source

EVALUATION OF PUBLIC GOODS -THE COUNTERPOINTS AND CONTRADICTIONS OF THE CROATIAN CONCEPT OF ‘GOODS OF INTEREST TO THE REPUBLIC OF CROATIA’

open access: yesZbornik Radova Pravnog Fakulteta u Splitu, 2009
In this paper the author analyses the dominant concept about ‘public things’ and in particular the question of the nature of public property. Also analysed are the viewpoints which see goods in public property as some kind of private property.
Branko Babac
doaj  

Overview of molecular signatures of senescence and associated resources: pros and cons

open access: yesFEBS Open Bio, EarlyView.
Cells can enter a stress response state termed cellular senescence that is involved in various diseases and aging. Detecting these cells is challenging due to the lack of universal biomarkers. This review presents the current state of senescence identification, from biomarkers to molecular signatures, compares tools and approaches, and highlights ...
Orestis A. Ntintas   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy